Articles originaux publiés dans des journaux à politique éditoriale

  • Sunaric Mégevand G., Salmon JF, Scholtz RP, Murray AD. The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. Ophthalmology 1995 ;102 : 84-90
  • Sunaric M égevand G, Salmon JF. The use of antimetabolites in glaucoma filtering surgery. South Af J of Ophthalmol 1994 ; 7 : 15-17
  • Sunaric Mégevand G, Pournaras CJ. Current approach to postoperative
    endophthalmitis. Perspective. Br J Ophthalmology 1997; 81: 1006-1015
  • Sunaric Mégevand G, Leuenberger PM. Follow-up after viscocanalostomy. American Journal of Ophthalmology 2001
  • Safran AB, Sunaric G, Burger A. The trap of the displaced blind spot in automated perimetry. Br J Ophthalmol 1993 ; 77 :254-255
  • Dosso A, Safran AB, Sunaric G, Burger A. Anterior ischemic optic neuropathy in Graves’ disease. J Neurophthalmol 1994 ; 14 : 170-174
  • Pournaras CJ, Issoua D, Saravelos S, Sunaric G. Candida chorioretinitis : current therapeutic approach. Klin Montatsbl Augenheilkd 1994 ; 204 :334-336
  • Sunaric Mégevand G. Le glaucome chronique post-traumatique. Méd et Hyg 1997 ; 55 : 2422-2424
  • Sunaric Mégevand G. Nouveautés dans le traitement médicamenteux du glaucome. Méd et Hyg 2001
  • Sunaric Mégevand G. Prise en charge du patient avec un glaucome.. Méd et Hyg 2000
  • Stangos AN, Whatham AR, Sunaric-Megevand G. Primary Viscocanalostomy for Juvenile Open-Angle Glaucoma. Am J Ophthalmol 2005; 140:484-490
  • Pechère-Bertschi A. Sunaric Mégevand G, Maillard M, Panarello F , Haefliger I. , Burnier M. Alterations of renal sodium handling in patients with normal tension glaucoma . Clinical Science. Jan 2007 Clinical Science
  • Katsimpris P, Petropoulos Y, Sunaric Mégevand G. Angel closure glaucoma and irido-ciliary cysts. Klinische Monatsblat dec 2007
  • Stangos AN, Sunaric Mégevand G. Combined Phaco-Viscocanalostomy. International Ophthalmology mai 2007 (1); 4: 1-8.
  • Stangos AN, Leuenberger P, Sunaric Mégevand. Learning curve after
    Viscocanalostomy Journal of Glaucoma 2012;21;408-414
  • Ingeborg Stalmans, Gordana Sunaric Mégevand , Francesca Cordeiro, Francisco Goni, Anton Hommer, Luca Rossetti, Anders Heijl, Alain Bron. Preservative free treatment in Glaucoma; who, when and why. Eu J Ophthalmology 2013
  • Sunaric-Megevand G,Leuenberger PM, Preußner PR . Assessment of the TriggerfishTM Contact. Lens Sensor for Measurement of Intraocular Pressure Variations Acta Ophthalmol 2014; 92(5):e414-5.
  • Mathysen DG, Ringens PJ, Midena E, Klett A, Sunaric-Mégevand G, Martinez-Costa R, Curtin D, Tassignon MJ, Aclimandos W, Creuzot-Garcher C, Grupcheva C. Procedural aspects of the organization of the comprehensive European Board of Ophthalmology Diploma examination. Educ Eval Health Prof. 2016 Jul 26;13:27
  • Sunaric-Mégevand G, Aclimandos W, Creuzot-Garcher C, Traverso CE, Tuulonen A, Hitchings R, Mathysen DG. Can ‘Fellow of the European Board of Ophthalmology Subspecialty Diploma in Glaucoma,’ a subspecialty examination on glaucoma induce the qualification standard of glaucoma clinical practice in Europe? J Educ Eval Health Prof. 2016 Jul 28;13:28.
  • Stalmans I, Oddone F, Cordeiro MF, Hommer A, Montesano G, Ribeiro L, Sunaric-Mégevand G, Rossetti L. Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial. Graefes Arch Clin Exp Ophthalmol. 2016 Jun;254(6):1151-8. doi: 10.1007/s00417-016-3299-9.
  • Aclimandos W, Mathysen DG, Creuzot-Garcher C, Sunaric-Mégevand G. Introduction of subspecialty examinations by the European Board of Ophthalmology (EBO) in close collaboration with European Subspecialty Ophthalmological Societies: FEBO-SA. Acta Ophthalmol. 2015 Dec;93(8):778-81. doi: 10.1111/aos.12738.

Published abstracts

  • Sunaric Mégevand G, Munoz JL, Fathi M, Pournaras CJ. Vitreal pharmacocinetics and retinal toxicity of fluconazole. Invest Ophthalmol Vis Sci 1996; 37 : 777
  • Sunaric Mégevand G. Follow-up after viscocanalostomy. Invest Ophthalmol Vis Sci 1999
  • Panarello F, Sunaric Mégevand G, Movaffaghy A, Riva Ch, Pournaras CJ Effect on the optic nerve blood flow after treatment with Latanoprost compared with Dorzolamide. Investig Ophthalmol Visc Sci 1999
  • Desmangles Ph, Sunaric Mégevand G, Safran AB. Fleeting scotomas Invest Ophthalmol Vis Sci 1999
  • Safran AB, Sunaric Mégevand G, Desmangles Ph. Fleeting scotomas

Book chapters

  • Sunaric Mégevand G. La douleur dans le glaucome. Douleur et l’œil, AB Safran 1998 Ed Méd et Hygiène.
  • Sunaric-Megevand G, Stangos AN. L’analyse de la couche des fibres nerveuses à l’aide du laser confocal à balayage polarisant – GDx. In: Schnyder C, Mermoud A, editors. Glaucome. Atlas en Ophtalmologie. Paris: Elsevier, 2005: 105-119 (ISBN: 2-84299-671-2).
  • Sunaric-Megevand G, Stangos AN. In: Schnyder C, Mermoud A, editors. Glaucome. Atlas en Ophtalmologie. Paris: Elsevier, 2005: 409-414 (ISBN: 2-84299-671-2).
  • IN process : EGS guideline , 4th edition in collaboration with the EGS

Posters

  • Sunaric Mégevand G, Pournaras CJ. La pharmacocinétique et toxicité rétinienne de la fluconazole. Poster. Congrès annuel de la Société Suisse d’Ophtalmologie, Genève sept. 1996.
  • Sunaric Mégevand G, Pournaras CJ. Vitreal pharmacocinetics and retinal toxicity of fluconazole. Poster. ARVO anuel meeting. Fort Lauderdale, may 1996.
  • Sunaric Mégevand G. Le comment et le pourquoi. Présentation de Vidéo. Congrès annuel de la Société Suisse d’Ophtalmologie, Lugano, sept 1997
  • Sunaric Mégevand G, Leuenberger PM. Follow-up of Viscocanalostomy. ARVO anual meeting Fort Lauderdale may 1999
  • Panarello F, Sunaric Mégevand G, Movaffaghy A, Riva Ch, Pournaras CJ. Effect on the optic nerve blood flow after treatment with Latanoprost compared with Dorzolamide. ARVO anual meeting, Frot Lauderdale may 1999
  • Desmangles Ph, Sunaric Mégevand G, Safran AB. Fleeting scotomas on the white Noise Field. ARVO anual meeting, Fort Sauderdale , may 1999
  • Sunaric Mégevand G, Durakovic O., PM Leuenberger. Chirurgie combinée: Viscocanalostomie versus trabéculectomie. Congrès annuel de la Société Suisse d’Ophtalmologie, Bern sept 2000.
  • Katsimpris Y. , Sunaric Mégevand G. Amplitude pulsatile oculaire mesurée avec la Smart Lens. Congrès annuel de la Société Suisse d’Ophtalmologie, Bern sept 2000.
  • Hengstler J, Sunaric Mégevand G. Atrophie essentielle de l’iris. Résultats de l’UBM. Congrès annuel de la Société Suisse d’Ophtalmologie, Bern sept 2000.
  • Stangos AAN, Sunaric Mégevand G. Primary Viscocanalostomy for juvenile open-angle glaucoma. Poster. American Academy of Ophthalmology. New Orleans, USA. October 2004
  • Stangos AAN, Sunaric Mégevand G, Panarello F, Leuenberger P. Viscocanalostomy as a treatment for the dysgenetic glaucomas. Poster. 4th International Glaucoma Symposium-IGS. Barcelona, Spain. March 2003.
  • Stangos AAN, Sunaric Mégevand G, Leuenberger PM. Learning curve for viscocanalostomy. 6th International Glaucoma Symposium, march 2007, Athens.
  • Roy S, Sunaric Mégevand G: HEALAFLOW in viscocanalostomy: comparison with conventional viscoelastics . XXIX ESCRS, Vienna sept 2011
  • Roy S, Sunaric Mégevand G, A Mermoud: HEALAFLOW in non penetrating surgery. World Glaucoma Congress Paris 2.7.2011
  • Roy S, Rizzato, A, Sunaric Mégevand G HEALAFLOW in Viscocanalostomy ARVO Fort Lauderdale Mai 5-10 2012
  • Lemmens S, Luyts M, Gerrits N, Ivanova A, Landtmeeters C, Peeters R, Simons AS, Vercauteren J, Sunaric-Mégevand G, Van Keer K, Molenberghs G, De Boever P, Stalmans I. Age-related changes in the fractal dimension of the retinal microvasculature, effects of cardiovascular risk factors and smoking behaviour. Acta Ophthalmol. 2021 Nov 7. doi: 10.1111/aos.15047.
  • Lemmens S, Rossetti L, Oddone F, Sunaric-Mégevand G, Hommer A, Vandewalle E, Francesca Cordeiro M, McNaught A, Montesano G, Stalmans I. Comparison of preserved bimatoprost 0.01% with preservative-free tafluprost: A randomised, investigator-masked, 3-month crossover, multicentre trial, SPORT II.
    Eur J Ophthalmol.
    2021 Apr 5:11206721211006573. doi: .
  • Lemmens S, Van Craenendonck T, Van Eijgen J, De Groef L, Bruffaerts R, de Jesus DA, Charle W, Jayapala M, Sunaric-Mégevand G, Standaert A, Theunis J, Van Keer K, Vandenbulcke M, Moons L, Vandenberghe R, De Boever P, Stalmans I. Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer’s disease patients Alzheimers Res Ther. 2020 Nov10;12(1):144
  • Sunaric Megevand G, Bron AM. Personalising surgical treatments for glaucoma patients. Prog Retin Eye Res. 2021 Mar;81:100879. doi: 10.1016/j.preteyeres.2020.100879. Epub 2020 Jun 18. PMID: 32562883 Review
  • Martin-Du Pan R, Pruijm M, Burnier M, Sunaric-Megevand G. Arterial hypertension and glaucoma: watch out for nocturnal blood pressure. Rev Med Suisse. 2016 Sep 14;12(530):1518-1521.
  • Aung T et al Sunaric Mégevand G: Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci.  Nat Genet. 2017 Jul;49(7):993-1004